Sinopharm Tech Holdings Limited (Stock Code: 8156) has published a form of proxy for its upcoming annual general meeting (AGM), which is scheduled for 19 December 2025 at 11:00 a.m., to be held at Units 1302–3, 13/F, Ruttonjee House, Ruttonjee Centre, 11 Duddell Street, Central, Hong Kong.

According to the document, shareholders are invited to receive and consider audited consolidated financial statements for the year ended 30 June 2025, along with directors’ and independent auditors’ reports. The meeting will further address the re-election of existing directors and the election of new independent non-executive directors. The proposal to re-appoint Suya WWC CPA Limited as auditors, together with the authorization to fix directors’ and auditors’ remuneration, will also be brought to vote.

The agenda includes granting general mandates to the board to issue and repurchase shares of the company. In addition, there is a resolution to extend the general mandate on share issuance by including any shares repurchased under the repurchase mandate. The form of proxy contains details on voting instructions and highlights a personal information collection statement setting out how shareholders’ and proxies’ data may be used in connection with the meeting.